RAPIBLYK (landiolol)

**Product type:** Human Prescription Drug

**Active ingredient:** LANDIOLOL HYDROCHLORIDE

**Strength:** 280 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** AOP Health US, LLC

**Marketing category:** NDA (NDA217202)

**Pharmacologic class:** Adrenergic beta1-Antagonists [MoA], beta-Adrenergic Blocker [EPC]